MedicineNet.com
About Us | Privacy Policy | Site Map
November 26, 2009
MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Picture Image Collection MedTerms medical dictionary
Font Size
A
A
A

Fatty Liver (cont.)

How common are NAFLD and NASH and who are at risk?

The NAFLD spectrum is probably the most common disease of the liver in the United States. Although precise information on the number of cases of NAFLD and NASH is limited, estimates have been made. Moreover, information is available on which individuals are at risk to develop NAFLD and NASH.

Why is information on the number of cases limited?

To date, no data are available on the incidence (number of new cases per year) of NAFLD or NASH in the United States, or anywhere else in the world for that matter. To determine the incidence of this disease, long-term studies in populations at risk will be needed. Such data collection has only just begun in several medical centers.

We do have data, however, on the prevalence (number of cases observed at one time) of NAFLD and NASH in cross-sections of populations at risk. Therefore, knowing which individuals are at risk is important. In this regard, a large body of evidence now supports the concept that NAFLD is associated with a condition called insulin resistance, which is described in more detail below. Suffice it to say at this point that diabetes mellitus type 2 (DM2) and, in addition, especially the overweight condition and obesity are the most recognizable features of insulin resistance.

What is the BMI and how does it relate to NAFLD and NASH?

As just indicated, obesity is linked closely to NAFLD. Therefore, to get a grasp on the frequency of NAFLD and NASH and the impact of obesity on NAFLD in the population, one has to understand how obesity is defined. A calculation of the body mass index (BMI) is a method that can be used to determine degrees of obesity.

The BMI is calculated by dividing a person's weight in kilograms by his or her height in meters squared (kg/m2). In the non-metric system, BMI = (lbs/inches2) x 703. In adults, normal weight is defined as a BMI between 20 and 25, overweight from 25 to 30, obesity from 30 to 35, significant obesity from 35 to 40, morbid obesity from 40 to 45, super obesity from 45 to 50, and super-morbid obesity greater than 50.

In addition to the BMI method, obesity can be described according to the distribution of body fat. Fat can be distributed predominantly either to the hips (gynoid or pear-shaped) or to the abdomen (central, android, or apple-shaped). An abdominal predominance of fat is the most commonly observed type of obesity in insulin resistance. Abdominal obesity is defined in men by a waist-to-hip circumference ratio greater than 1.0 or a waist circumference greater than 40 inches (102 centimeters). In women, abdominal obesity is defined by a waist-to-hip ratio greater than 0.8 or a waist circumference greater than 35 inches (88 centimeters). In fact, simple waist measurements alone seem to be the best predictor of the type of body fat distribution that is most closely associated with insulin resistance.

The normal limits that have been established for the BMI and waist circumference are not based on considerations of appearance. Rather, they are based on the significant risk of developing complications due to being overweight (BMI-related morbidity), such as coronary artery heart disease and diabetes. In children, however, normal ranges of the BMI vary according to age and gender. Furthermore, up until the age of 16, the upper limits for the normal BMI are lower than 25. Therefore, in children, the degree of overweight is more often expressed as a percentage above ideal body weight.



Next: What are the estimated numbers of cases of NAFLD and NASH? »

Fatty Liver - How Was Diagnosis Established

The MedicineNet physician editors ask:

The symptoms of fatty liver can vary greatly from patient to patient. What were your symptoms at the onset of your disease?

Comment submissions for this question have ended. Patient Discussions FAQs
See 20 Viewer Comments

View Comments


Printer-Friendly Format  |  Email to a Friend


Suggested Reading by Our Doctors
MedicineNet Doctors
  • Statins - Read about statins, cholesterol lowering medications like Levacor, Zocor, Pravachol, Lipitor, Crestor, and more. Side effects, drug interactions, and patient information is also provided.
  • Liver Blood Tests - Learn about liver blood tests used to detect liver damage disease such as fatty liver, cirrhosis, hepatitis, Tylenol liver damage, and more. This includes measuring the aminotransferases enzymes (AST and ALT levels)
  • Abdominal Pain - Learn about abdominal pain (pain in the stomach / abdomen) including causes, symptoms, how abdominal pain is diagnosed, and how abdominal pain is treated.

Latest Medical News


Women's Health

Find out what women really need.


Are you Depressed? Take the Quiz

Your Guide to Symptoms & Signs: Pinpoint Your Pain












Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.